Thousands of children benefit from newer HIV treatment South Africa has taken a significant step in paediatric HIV care with the introduction of a child-friendly version of the antiretroviral drug dolutegravir in 2022. This rollout has marked a turning point in the management of HIV for children aged one to four, significantly improving treatment adherence … Continue reading Child-friendly dolutegravir rollout and its impact